Uptake of new hemophilia gene therapies slow as field assess

By Deena Beasley (Reuters) - High cost, logistical issues and the prospect of potential treatment advances are holding back adoption of the first gene...

Related Keywords

San Diego , California , United States , American , America , Michael Recht , Caroline Humer , Bob Lojewski , Biomarin Roctavian , Margaret Ragni , Deena Beasley , National Bleeding Disorders Foundation , Pfizer , Reuters , American Society Of Hematology , University Of Pittsburgh , American Society , Reporting By Deena Beasley , Bill Berkrot , ,